Angel News

Angel News

Back to Homepage

16th December 2019

Riverside naturally completes another successful deal

The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in HealthTech BioActives S.L. (“HTBA”), a Spanish manufacturer of active pharmaceutical ingredients (APIs), excipients, flavorings and sweeteners for the pharmaceutical, nutraceutical and cosmetic industries, as well as ingredients for human and animal feed with a total sales of €51 million in 2018. The company’s products, derived from citrus and vitamin B12 derivatives, sell in more than 90 countries worldwide. HTBA is a carve-out of Ferrer, a well- known international pharmaceutical company headquartered in Barcelona, Spain. 


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage